<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this study was to estimate whether prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in adult European diabetic patients is associated with type of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A consecutive series of patients attending hospital-based <z:mp ids='MP_0002055'>diabetes</z:mp> clinics were assessed for the frequency of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and compared with population-based control subjects as part of the Action LADA study </plain></SENT>
<SENT sid="2" pm="."><plain>In total, 2,011 subjects (aged 30-70 years) were studied, including 1,247 patients with recent-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> without glutamic acid decarboxylase autoantibodies (GADAs), 117 non-insulin-requiring patients with GADAs who had not received insulin therapy for at least 6 months after diagnosis (designated latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> of adults [LADA]), 288 type 1 diabetic patients, and 359 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Frequency of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was significantly different in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (31.9%) and LADA (41.9%) (P = 0.015) and in both conditions was less frequent than in type 2 diabetic patients (88.8%) (P &lt; 0.0001 for each) </plain></SENT>
<SENT sid="4" pm="."><plain>Eliminating <z:chebi fb="105" ids="17234">glucose</z:chebi> as a variable, the prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was similar in patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> (type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or LADA) (17.3%) and control subjects (23.7%) but remained more common in type 2 diabetic patients (47.8%) (P = 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo> groups) </plain></SENT>
<SENT sid="5" pm="."><plain>In both type 1 diabetic patients and those with LADA, individual components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> were similar but less common than in type 2 diabetic patients (P &lt; 0.0001 for each) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is significantly higher in type 2 diabetic patients than in patients with LADA or adults with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Excluding <z:chebi fb="105" ids="17234">glucose</z:chebi> as a variable, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is not more prevalent in patients with autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> than in control subjects </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> is not a characteristic of autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>